Professor Andrew Briggs

BSc (Hons) MSc DPhil


15-17 Tavistock Place
United Kingdom

Professor of Health Economics at the London School of Hygiene & Tropical Medicine, and co-Director of the Global Health Economics Centre at the school, along with Anna Vassall and Mark Jit.  I  previously held the William R Lindsay Chair in Health Economics at the University of Glasgow.  Following a sabbatical at Memorial Sloan Kettering Cancer Center, New York in 2016/17, I remain a Visiting Investigator, collaborating with Dr Peter Bach on value frameworks for oncology medications.

I have  co-authored two textbooks, one published by OUP entitled Decision Modelling for Health Economic Evaluation, and the other published by Wiley entitled Statistical Methods for Cost-Effectiveness Analysis.

I am also Series Editor for OUP's Handbooks in Health Economic Evaluation series.

A link to my GooGle Scholar page:


Department of Health Services Research and Policy
Faculty of Public Health and Policy


Centre for Statistical Methodology
Global Health Economics Centre


Our highly successful Foundations and Advanced Decision Modelling for Health Economic Evaluation courses have been developed for online delivery and include, as a new element for 2021, the ability to follow the practical exercises in the statistical package R as well as in Excel.

For full details and to book a place on the upcoming courses in May and June 2022, please visit the course website.


My main methodological focus of research has been health economic evaluation, particularly statistical methods for cost-effectiveness analysis.  This includes statistical methods for estimation of parameters for cost-effectiveness models as well as statistical analysis of cost-effectiveness alongside clinical trials.  I have a more general interest in epidemiological methods, in particular the use of prognostic scoring methods for predicting health outcomes and the relationship with heterogeneity in cost-effectiveness analysis.

Research Area
Decision analysis
Economic evaluation
Randomised controlled trials
Health economics
United Kingdom
United States of America
South Africa
European Union
North America
Sub-Saharan Africa (all income levels)

Selected Publications

The impact of moderate and severe asthma exacerbations on quality of life: a post hoc analysis of randomised controlled trial data.
Briggs A; Nasser S; Hammerby E; Buchs S; Virchow JC
Journal of patient-reported outcomes
Mendelian randomization: estimation of inpatient hospital costs attributable to obesity.
Dick K; Schneider JE; Briggs A; Lecomte P; Regnier SA; Lean M
Health economics review
Developing a Framework for the Health Technology Assessment of Histology-independent Precision Oncology Therapies.
Gaultney JG; Bouvy JC; Chapman RH; Upton AJ; Kowal S; Bokemeyer C; Solà-Morales O; Wolf J; Briggs AH
Applied health economics and health policy
Three Versus Six Months of Adjuvant Doublet Chemotherapy for Patients With Colorectal Cancer: A Multi-Country Cost-Effectiveness and Budget Impact Analysis.
Hanna CR; Robles-Zurita JA; Briggs A; Harkin A; Kelly C; McQueen J; Allan K; Pearson S; Hollander H; Glimelius B
Clinical colorectal cancer
Stratified medicine using invasive coronary function testing in angina: A cost-effectiveness analysis of the British Heart Foundation CorMicA trial.
Heggie R; Briggs A; Stanley B; Good R; Rocchiccioli P; McEntegart M; Watkins S; Eteiba H; Shaukat A; Lindsay M
International journal of cardiology
Estimating (quality-adjusted) life-year losses associated with deaths: With application to COVID-19.
Briggs AH; Goldstein DA; Kirwin E; Meacock R; Pandya A; Vanness DJ; Wisløff T
Health economics
See more Publications